Provided by Tiger Trade Technology Pte. Ltd.

COSMOS HEALTH INC

0.2247
+0.00853.93%
Pre-market: 0.22990.0052+2.31%05:11 EDT
Volume:3.77M
Turnover:863.42K
Market Cap:22.69M
PE:-0.36
High:0.2388
Open:0.2224
Low:0.2189
Close:0.2162
52wk High:1.32
52wk Low:0.1616
Shares:101.00M
Float Shares:78.78M
Volume Ratio:2.25
T/O Rate:4.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6204
EPS(LYR):-0.6321
ROE:-104.00%
ROA:-18.42%
PB:1.10
PE(LYR):-0.36

Loading ...

BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029

Reuters
·
May 26

Cosmos Health forecasts 2029 revenue of $200.6 million

Reuters
·
May 26

Cosmos Health- Projects 2029 Stockholders' Equity of $92.3 Mln & per-Share Value Creation With $0.73 EPS

THOMSON REUTERS
·
May 26

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted Ebitda by 2029 — Building an Innovative, High-Margin Healthcare Platform With Strong Cash Generation

THOMSON REUTERS
·
May 26

Cosmos Health Inc - Expects Profitability in 2027, Net Income $31 Mln by 2029

THOMSON REUTERS
·
May 26

Cosmos Health announces annual shareholder meeting

Reuters
·
May 23

Cosmos Health says 4,874,126 Series B warrants expire unexercised

Reuters
·
May 22

Cosmos Health Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $17.928M Miss $21.893M Estimate

Benzinga Earnings
·
May 21

Cosmos Health Q1 FY26 net loss widens to $2.81 million; revenue rises 30.7% to $17.93 million

Reuters
·
May 21

BRIEF-Cosmos Health Q1 Revenue USD 17.9 Million

Reuters
·
May 21

Cosmos Health Q1 Operating Expenses USD 3.57 Million

THOMSON REUTERS
·
May 21

Cosmos Health delays filing Q1 10-Q after XBRL, information compilation delays

Reuters
·
May 16

Cosmos Health pursues research, development financing program with EIB

TIPRANKS
·
May 14

Cosmos Health announces withdrawal of registration statement on Form S-1

TIPRANKS
·
May 13

Cosmos Health forecasts Fort18 adds over $3.2 million annual US revenue in 12-18 months

Reuters
·
May 12

Cosmos Health Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 11

Zacks Small-Cap Research reiterates Cosmos Health valuation target at $4.5

Reuters
·
May 08

Cosmos Health sees Cur18 generating over $2.5 million annual US revenue in 12-18 months

Reuters
·
May 01

Cosmos Health expects Liv18 to generate over $5 million annual revenue

Reuters
·
Apr 20

Cosmos Health announces planned U.S. market launch of Cur18b

TIPRANKS
·
Apr 18